Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
08/18/2023 | KalVista Pharmaceuticals, Inc. | KALV | Sale | Common Stock | 7.1k | $10.73 | $76.6k | | 08/17/2023 |
08/17/2023 | KalVista Pharmaceuticals, Inc. | KALV | Exercise | Restricted Stock Unit | 1.8k | $0.00 | $0 | | 08/17/2023 |
08/17/2023 | KalVista Pharmaceuticals, Inc. | KALV | Exercise | Restricted Stock Unit | 2.4k | $0.00 | $0 | | 08/17/2023 |
08/17/2023 | KalVista Pharmaceuticals, Inc. | KALV | Exercise | Performance Stock Unit | 7.3k | $0.00 | $0 | | 08/17/2023 |
05/18/2023 | KalVista Pharmaceuticals, Inc. | KALV | Sale | Common Stock | 2.6k | $10.14 | $26.4k | | 01/11/2023 |
05/17/2023 | KalVista Pharmaceuticals, Inc. | KALV | Exercise | Restricted Stock Unit | 2.4k | $0.00 | $0 | | 01/11/2023 |
05/17/2023 | KalVista Pharmaceuticals, Inc. | KALV | Exercise | Restricted Stock Unit | 1.8k | $0.00 | $0 | | 01/11/2023 |
02/17/2023 | KalVista Pharmaceuticals, Inc. | KALV | Exercise | | 2.4k | $0.00 | $0 | | 02/17/2023 |
02/17/2023 | KalVista Pharmaceuticals, Inc. | KALV | Sale | Common Stock | 2.7k | $7.66 | $20.9k | | 02/17/2023 |
02/17/2023 | KalVista Pharmaceuticals, Inc. | KALV | Exercise | Performance Restricted Stock Unit | 2.4k | $0.00 | $0 | | 02/17/2023 |
02/17/2023 | KalVista Pharmaceuticals, Inc. | KALV | Exercise | Restricted Stock Unit | 1.8k | $0.00 | $0 | | 02/17/2023 |
01/11/2023 | KalVista Pharmaceuticals, Inc. | KALV | Grant | Restricted Stock Unit | 29.2k | $0.00 | $0 | | 01/11/2023 |
11/18/2022 | KalVista Pharmaceuticals, Inc. | KALV | Sale | Common Stock | 1.1k | $5.44 | $6.2k | | 11/21/2022 |
11/17/2022 | KalVista Pharmaceuticals, Inc. | KALV | Exercise | Restricted Stock Unit | 1.8k | $0.00 | $0 | | 11/21/2022 |
08/17/2022 | KalVista Pharmaceuticals, Inc. | KALV | Exercise | Restricted Stock Unit | 1.8k | $0.00 | $0 | | 08/17/2022 |
08/17/2022 | KalVista Pharmaceuticals, Inc. | KALV | Sale | Common Stock | 1.1k | $14.96 | $17.1k | | 08/17/2022 |
11/01/2021 | KalVista Pharmaceuticals, Inc. | KALV | Sale | Common Stock | 5k | $18.07 | $90.3k | | 11/01/2021 |
08/02/2021 | KalVista Pharmaceuticals, Inc. | KALV | Sale | Common Stock | 5k | $20.52 | $102.6k | | 08/02/2021 |
05/26/2021 | KalVista Pharmaceuticals, Inc. | KALV | Grant | Employee Stock Option (Right to Buy) | 60k | $25.95 | $1.6M | | 05/26/2021 |
05/03/2021 | KalVista Pharmaceuticals, Inc. | KALV | Sale | Common Stock | 5k | $24.84 | $124.2k | | 05/03/2021 |
02/23/2021 | KalVista Pharmaceuticals, Inc. | KALV | Sale | Common Stock | 500 | $31.87 | $15.9k | | 02/23/2021 |
02/23/2021 | KalVista Pharmaceuticals, Inc. | KALV | Sale | Common Stock | 3.3k | $32.94 | $109.1k | | 02/23/2021 |
02/23/2021 | KalVista Pharmaceuticals, Inc. | KALV | Sale | Common Stock | 10.4k | $33.74 | $350.6k | | 02/23/2021 |
02/23/2021 | KalVista Pharmaceuticals, Inc. | KALV | Sale | Common Stock | 800 | $35.39 | $28.3k | | 02/23/2021 |
02/07/2021 | KalVista Pharmaceuticals, Inc. | KALV | Grant | Stock Option (right to buy) | 20k | $10.20 | $204k | | 02/07/2021 |
02/07/2021 | KalVista Pharmaceuticals, Inc. | KALV | Grant | Stock Option (right to buy) | 31k | $24.23 | $751.1k | | 02/07/2021 |
12/16/2020 | KalVista Pharmaceuticals, Inc. | KALV | Grant | Stock Option (right to buy) | 80k | $10.20 | $816k | | 12/16/2020 |
10/29/2020 | KalVista Pharmaceuticals, Inc. | KALV | Sale | Common Stock | 5k | $17.48 | $87.4k | | 10/29/2020 |
10/21/2020 | KalVista Pharmaceuticals, Inc. | KALV | Sale | Common Stock | 3.5k | $17.68 | $61.9k | | 10/20/2020 |
10/21/2020 | KalVista Pharmaceuticals, Inc. | KALV | Sale | Common Stock | 2.5k | $19.02 | $48.4k | | 10/20/2020 |
10/20/2020 | KalVista Pharmaceuticals, Inc. | KALV | Sale | Common Stock | 5.6k | $17.27 | $97.4k | | 10/20/2020 |
10/20/2020 | KalVista Pharmaceuticals, Inc. | KALV | Sale | Common Stock | 2.3k | $18.01 | $41.5k | | 10/20/2020 |
10/16/2020 | KalVista Pharmaceuticals, Inc. | KALV | Sale | Common Stock | 914 | $17.00 | $15.5k | | 10/16/2020 |
02/05/2020 | KalVista Pharmaceuticals, Inc. | KALV | Sale | Common Stock | 100 | $17.10 | $1.7k | | 02/05/2020 |
12/20/2019 | KalVista Pharmaceuticals, Inc. | KALV | Sale | Common Stock | 2.6k | $17.02 | $45k | | 12/20/2019 |
|